DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Vaishali Pharma Limited — Outcome of Board Meeting

NSE 54 min ago·14 Aug 2026, 10:25 am

Vaishali Pharma

Vaishali Pharma has informed stock exchanges that it has submitted its financial results for the period ending June 30, 2026. This submission is a routine regulatory requirement that allows the company to disclose its performance to the public.

For investors, the release of these results is significant as it provides the first official data on the company's financial health. It offers clarity on revenue, profitability, and operational efficiency, which are key factors for evaluating the company's current standing and future growth prospects.

Investors should monitor the specific details within the report, particularly the earnings per share and net profit margins. These figures will help determine if the company is meeting its targets and provide insight into its trajectory for the upcoming quarters.